Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Lidereau, R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 118 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bieche, I; Franc, B; Vidaud, D; Vidaud, M; Lidereau, R
      Analyses of MYC, ERBB2, and CCND1 genes in benign and malignant thyroid follicular cell tumors by real-time polymerase chain reaction

      THYROID
    2. Bieche, I; Parfait, B; Laurendeau, I; Girault, I; Vidaud, M; Lidereau, R
      Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer

      ONCOGENE
    3. Bieche, I; Parfait, B; Nogues, C; Andrieu, C; Vidaud, D; Spyratos, F; Lidereau, R; Vidaud, M
      The CGA gene as new predictor of the response to endocrine therapy in ER alpha-positive postmenopausal breast cancer patients

      ONCOGENE
    4. Jacquemier, J; Lidereau, R; Birnbaum, D; Eisinger, F; Sobol, H
      Assessing the risk of BRCA1-associated breast cancer using individual morphological criteria

      HISTOPATHOLOGY
    5. Bieche, I; Onody, P; Lerebours, F; Tozlu, S; Hacene, K; Andrieu, C; Vidaud, M; Tubiana-Hulin, M; Spyratos, F; Lidereau, R
      ERBB2 status and benefit from adjuvant tamoxifen in ER alpha-positive postmenopausal breast carcinoma

      CANCER LETTERS
    6. Giovangrandi, Y; Parfait, B; Asheuer, M; Olivi, M; Lidereau, R; Vidaud, M; Bieche, I
      Analysis of the human CGB/LHB gene cluster in breast tumors by real-time quantitative RT-PCR assays

      CANCER LETTERS
    7. Bieche, I; Parfait, A; Tozlu, S; Lidereau, R; Vidaud, M
      Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated gene

      CARCINOGENESIS
    8. Bertheau, P; Plassa, LF; Lerebours, F; de Roquancourt, A; Turpin, E; Lidereau, R; de The, H; Janin, A
      Allelic loss detection in inflammatory breast cancer: Improvement with laser microdissection

      LABORATORY INVESTIGATION
    9. Latil, A; Bieche, I; Vidaud, D; Lidereau, R; Berthon, P; Cussenot, O; Vidaud, M
      Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays

      CANCER RESEARCH
    10. Bieche, I; Parfait, B; Le Doussal, V; Olivi, M; Rio, MC; Lidereau, R; Vidaud, M
      Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: An outstanding candidate marker to predict the response to endocrine therapy

      CANCER RESEARCH
    11. Onody, P; Bertrand, F; Muzeau, F; Bieche, I; Lidereau, R
      Fluorescence in situ hybridization and immunohistochemical assays for HER-2/neu status determination - Application to node-negative breast cancer

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    12. de Pinieux, G; Legrier, ME; Poirson-Bichat, F; Courty, Y; Bras-Goncalves, R; Dutrillaux, AM; Nemati, F; Oudard, S; Lidereau, R; Broqua, P; Junien, JL; Dutrillaux, B; Poupon, MF
      Clinical and experimental progression of a new model of human prostate cancer and therapeutic approach

      AMERICAN JOURNAL OF PATHOLOGY
    13. Bieche, I; Nogues, C; Paradis, V; Olivi, R; Bedossa, P; Lidereau, R; Vidaud, M
      Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay

      CLINICAL CANCER RESEARCH
    14. Bieche, I; Lidereau, R
      Loss of heterozygosity at 13q14 correlates with RB1 cone underexpression in human breast cancer

      MOLECULAR CARCINOGENESIS
    15. Spyratos, F; Andrieu, C; Vidaud, D; Briffod, M; Vidaud, M; Lidereau, R; Bieche, I
      CCND1 mRNA overexpression is highly related to estrogen receptor positivity but not to proliferative markers in primary breast cancer

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    16. Latil, A; Bieche, I; Pesche, S; Valeri, A; Fournier, G; Cussenot, O; Lidereau, R
      VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms

      INTERNATIONAL JOURNAL OF CANCER
    17. Latil, A; Vidaud, D; Valeri, A; Fournier, G; Vidaud, M; Lidereau, R; Cussenot, O; Bieche, I
      htert expression correlates with myc over-expression in human prostate cancer

      INTERNATIONAL JOURNAL OF CANCER
    18. Lidereau, R; Eisinger, F; Champeme, MH; Nogues, C; Bieche, I; Birnbaum, D; Pallud, C; Jacquemier, J; Sobol, H
      Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer

      CANCER RESEARCH
    19. Curmi, PA; Nogues, C; Lachkar, S; Carelle, N; Gonthier, MP; Sobel, A; Lidereau, R; Bieche, I
      Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours

      BRITISH JOURNAL OF CANCER
    20. Mazoyer, S; Leary, J; Kirk, J; Fleischmann, E; Wagner, T; Claes, K; Messiaen, L; Foulkes, W; Desrochers, M; Simard, J; Phelan, CM; Kwan, E; Narod, SA; Vahteristo, P; Nevanlinna, H; Durando, X; Bignon, YJ; Peyrat, JP; Bonnardel, C; Sinilnikova, OM; Puget, N; Lenoir, GM; Mazoyer, S; Audoynaud, C; Goldgar, D; Maugard, C; Caux, V; Gad, S; Stoppa-Lyonnet, D; Nogues, C; Lidereau, R; Machavoine, C; Bressac-de Paillerets, B; Kuschel, B; Betz, B; Niederacher, D; Beckmann, MW; Hamann, U; Gayther, SA; Ponder, BAP; Robinson, M; Taylor, GR; Bishop, T; Catteau, A; Solomon, E; Cohen, B; Steel, M; Collins, N; Stratton, M; van der Looij, M; Olah, E; Miller, NJ; Barton, DE; Sverdlov, RS; Friedman, E; Radice, P; Montagna, M; Sensi, E; Caligo, M; van Eijk, R; Devilee, P; van der Luijt, R; Heimdal, K; Moller, P; Borg, A; Diez, O; Cortes, J; Domenech, M; Baiget, M; Osorio, A; Benitez, J; Borg, A; Maillet, P; Sappino, AP; Ozdag, H; Ozcelik, T; Ozturk, M; Rohlfs, EM; Boyd, J; McDermott, D; Offit, K; Unger, M; Nathanson, K; Weber, BL; Sellers, TA; Hampton, E; Couch, FJ; Neuhausen, S
      The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations

      AMERICAN JOURNAL OF HUMAN GENETICS
    21. Laake, K; Launonen, V; Niederacher, D; Gudlaugsdottir, S; Seitz, S; Rio, P; Champeme, MH; Bieche, I; Birnbaum, D; White, G; Sztan, M; Sever, N; Plummer, S; Osorio, A; Broeks, A; Huusko, P; Spurr, N; Borg, A; Cleton-Jansen, AM; van't Veer, L; Benitez, J; Casey, G; Peterlin, B; Olah, E; Varley, J; Bignon, YJ; Scherneck, S; Sigurdardottir, V; Lidereau, R; Eyfjord, J; Beckmann, MW; Winqvist, R; Skovlund, E; Borresen-Dale, AL
      Loss of heterozygosity at 11q23.1 and survival in breast cancer: Results of a large European study

      GENES CHROMOSOMES & CANCER
    22. Bieche, I; Khodja, A; Lidereau, R
      Deletion mapping of chromosomal region 1p32-pter in primary breast cancer

      GENES CHROMOSOMES & CANCER
    23. Bieche, I; Nogues, C; Lidereau, R
      Overexpression of BRCA2 gene in sporadic breast tumours

      ONCOGENE
    24. Zeng, WR; Watson, P; Lin, J; Jothy, S; Lidereau, R; Park, M; Nepveu, A
      Refined mapping of the region of loss of heterozygosity on the long arm ofchromosome 7 in human breast cancer defines the location of a second tumorsuppressor gene at 7q22 in the region of the CUTL1 gene

      ONCOGENE
    25. Tsarfaty, I; Alvord, WG; Resau, JH; Altstock, RT; Lidereau, R; Bieche, I; Bertrand, F; Horev, J; Klabansky, RL; Keydar, I; Vande Woude, GF
      Alteration of Met protooncogene product expression and prognosis in breastcarcinomas

      ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY
    26. Latil, A; Pesche, S; Valeri, A; Fournier, G; Cussenot, O; Lidereau, R
      Expression and mutational analysis of the MADR2/smad2 gene in human prostate cancer

      PROSTATE
    27. Latil, A; Bieche, I; Pesche, S; Volant, A; Valeri, A; Fournier, G; Cussenot, O; Lidereau, R
      Loss of heterozygosity at chromosome arm 13q and RB1 status in human prostate cancer

      HUMAN PATHOLOGY
    28. Eisinger, F; Nogues, C; Guinebretiere, JM; Peyrat, JP; Bardou, VJ; Noguchi, T; Vennin, P; Sauvin, R; Lidereau, R; Birnbaum, D; Jacquemier, J; Sobol, H
      Novel indications for BRCA1 screening using individual clinical and morphological features

      INTERNATIONAL JOURNAL OF CANCER
    29. Jacquemier, J; Eisinger, F; Nogues, C; Sun, ZZ; Guinebretiere, JM; Peyrat, JP; Geneix, J; Lidereau, R; Birnbaum, D; Sobol, H
      Histological type and syncytial growth pattern affect E-cadherin expression in a multifactorial analysis of a combined panel of sporadic and BRCA1-associated breast cancers

      INTERNATIONAL JOURNAL OF CANCER
    30. Zborovskaya, I; Gasparian, A; Karseladze, A; Elcheva, T; Trofimova, E; Driouch, K; Trassard, M; Tatosyan, A; Lidereau, R
      Somatic genetic alterations (LOH) in benign, borderline and invasive ovarian tumours: Intratumoral molecular heterogeneity

      INTERNATIONAL JOURNAL OF CANCER
    31. Bieche, I; Champeme, MH; Lidereau, R
      Infrequent mutations of the MET gene in sporadic breast tumours

      INTERNATIONAL JOURNAL OF CANCER
    32. Latil, A; Pesche, S; Valeri, A; Cussenot, O; Fournier, G; Lidereau, R
      Common Delta 2 and Delta 8 RB1 variants in human breast and prostate tissues

      INTERNATIONAL JOURNAL OF CANCER
    33. Bieche, I; Onody, P; Laurendeau, I; Olivi, M; Vidaud, D; Lidereau, R; Vidaud, M
      Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications

      CLINICAL CHEMISTRY
    34. Bieche, I; Laurendeau, I; Tozlu, S; Olivi, M; Vidaud, D; Lidereau, R; Vidaud, M
      Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay

      CANCER RESEARCH
    35. Bieche, I; Lidereau, R
      Increased level of exon 12 alternatively spliced BRCA2 transcripts in tumor breast tissue compared with normal tissue

      CANCER RESEARCH
    36. Launonen, V; Laake, K; Huusko, P; Niederacher, D; Beckmann, MW; Barkardottir, RB; Geirsdottir, EK; Gudmundsson, J; Rio, P; Bignon, YJ; Seitz, S; Scherneck, S; Bieche, I; Champeme, MH; Birnbaum, D; White, G; Varley, J; Sztan, M; Olah, E; Osorio, A; Benitez, J; Spurr, N; Velikonja, N; Peterlin, B; Borg, A; Cleton-Jansen, AM; Devilee, P; Bloigu, R; Lidereau, R; Borresen-Dale, AL; Winqvist, R
      European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables

      BRITISH JOURNAL OF CANCER
    37. BIECHE I; LAZAR V; NOGUES C; POYNARD T; GIOVANGRANDI Y; BELLET D; LIDEREAU R; VIDAUD M
      PROGNOSTIC VALUE OF CHORIONIC-GONADOTROPIN BETA-GENE TRANSCRIPTS IN HUMAN BREAST-CARCINOMA

      Clinical cancer research
    38. BIECHE I; LAZAR V; NOGUES C; POYNARD T; GIOVANGRANDI Y; BELLET D; LIDEREAU R; VIDAUD M
      PROGNOSTIC VALUE OF CHORIONIC-GONADOTROPIN BETA-GENE TRANSCRIPTS IN HUMAN BREAST-CARCINOMA

      Clinical cancer research
    39. BIECHE I; LATIL A; BECETTE V; LIDEREAU R
      STUDY OF FHIT TRANSCRIPTS IN NORMAL AND MALIGNANT BREAST-TISSUE

      Genes chromosomes & cancer (Print)
    40. ADELAIDE J; CHAFFANET M; IMBERT A; ALLIONE F; GENEIX J; POPOVICI C; VANALEWIJK D; TRAPMAN J; ZEILLINGER R; BORRESENDALE AL; LIDEREAU R; BIRNBAUM D; PEBUSQUE MJ
      CHROMOSOME REGION 8P11-P21 - REFINED MAPPING AND MOLECULAR ALTERATIONS IN BREAST-CANCER

      Genes, chromosomes & cancer
    41. ZHOU XP; HOANG JM; LI YJ; SERUCA R; CARNEIRO F; SOBRINHOSIMOES M; LOTHE RA; GLEESON CM; RUSSELL SEH; MUZEAU F; FLEJOU JF; HOANGXUAN K; LIDEREAU R; THOMAS G; HAMELIN R
      DETERMINATION OF THE REPLICATION ERROR PHENOTYPE IN HUMAN TUMORS WITHOUT THE REQUIREMENT FOR MATCHING NORMAL DNA BY ANALYSIS OF MONONUCLEOTIDE REPEAT MICROSATELLITES

      Genes, chromosomes & cancer
    42. BIECHE I; KHODJA A; LIDEREAU R
      DELETION MAPPING IN BREAST-TUMOR CELL-LINES POINTS TO 2 DISTINCT TUMOR-SUPPRESSOR GENES IN THE 1P32-PTER REGION, ONE OF DELETED REGIONS (1P36.2) BEING LOCATED WITHIN THE CONSENSUS REGION OF LOH IN NEUROBLASTOMA

      Oncology Reports
    43. WANG Q; DRIOUCH K; COURTOIS S; CHAMPEME MH; BIECHE I; TREILLEUX I; BRIFFOD M; RIMOKH R; MAGAUD JP; CURMI P; LIDEREAU R; PUISIEUX A
      LOW-FREQUENCY OF TSG101 CC2 GENE ALTERATIONS IN INVASIVE HUMAN BREASTCANCERS/

      Oncogene
    44. PESCHE S; LATIL A; MUZEAU F; CUSSENOT O; FOURNIER G; LONGY M; ENG C; LIDEREAU R
      PTEN MMAC1/TEP1 INVOLVEMENT IN PRIMARY PROSTATE CANCERS/

      Oncogene
    45. LATIL A; BIECHE I; FOURNIER G; CUSSENOT O; PESCHE S; LIDEREAU R
      MOLECULAR ANALYSIS OF THE FHIT GENE IN HUMAN PROSTATE-CANCER

      Oncogene
    46. LATIL A; LIDEREAU R
      GENETIC-ASPECTS OF PROSTATE-CANCER

      Virchows Archiv
    47. Devilee, P; Barkardottir, RB; Bevilacqua, G; Bignon, YJ; Bishop, T; Borg, A; Borresen-Dale, AL; Chang-Claude, J; Easton, D; Eyfjord, J; Feunteun, J; Goldgar, D; Haites, N; Holm, N; Kruse, T; Larsson, C; Lenoir, G; Lidereau, R; Nevanlinna, H; Ponder, B; Scherneck, S; Schmitt, F; Sobol, H; Solomon, E; Spurr, N; Steel, M; Stratton, M; Varley, J; Vasen, H; Vassilaros, S; Wagner, T; Willems, P; Winqvist, R
      Genetics and epidemiology of hereditary breast cancer

      CANCER RESEARCH SUPPORTED UNDER BIOMED I
    48. BIECHE I; OLIVI M; CHAMPEME MH; VIDAUD D; LIDEREAU R; VIDAUD M
      NOVEL-APPROACH TO QUANTITATIVE POLYMERASE-CHAIN-REACTION USING REAL-TIME DETECTION - APPLICATION TO THE DETECTION OF GENE AMPLIFICATION IN BREAST-CANCER

      International journal of cancer
    49. PHELAN CM; BORG A; CUNY M; CRICHTON DN; BALDERSSON T; ANDERSEN TI; CALIGO MA; LIDEREAU R; LINDBLOM A; SEITZ S; KELSELL D; HAMANN K; RIO P; THORLACIUS S; PAPP J; OLAH E; PONDER B; BIGNON YJ; SCHERNECK S; BARKARDOTTIR R; BORRESENDALE AL; EYFJORD J; THEILLET C; THOMPSON AM; DEVILEE P; LARSSON C
      CONSORTIUM STUDY ON 1280 BREAST CARCINOMAS - ALLELIC LOSS ON CHROMOSOME-17 TARGETS SUBREGIONS ASSOCIATED WITH FAMILY HISTORY AND CLINICAL-PARAMETERS

      Cancer research
    50. DRIOUCH K; BRIFFOD M; BIECHE I; CHAMPEME MH; LIDEREAU R
      LOCATION OF SEVERAL PUTATIVE GENES POSSIBLY INVOLVED IN HUMAN BREAST-CANCER PROGRESSION

      Cancer research
    51. BIECHE I; LACHKAR S; BECETTE V; CIFUENTESDIAZ C; SOBEL A; LIDEREAU R; CURMI PA
      OVEREXPRESSION OF THE STATHMIN GENE IN A SUBSET OF HUMAN BREAST-CANCER

      British Journal of Cancer
    52. BERTHON P; VALERI A; COHENAKENINE A; DRELON E; PAISS T; WOHR G; LATIL A; MILLASSEAU P; MELLAH I; COHEN N; BLANCHE H; BELLANECHANTELOT C; DEMENAIS F; TEILLAC P; LEDUC A; DEPETRICONI R; HAUTMANN R; CHUMAKOV I; BACHNER L; MAITLAND NJ; LIDEREAU R; VOGEL W; FOURNIER G; MANGIN P; COHEN D; CUSSENOT O
      PREDISPOSING GENE FOR EARLY-ONSET PROSTATE-CANCER, LOCALIZED ON CHROMOSOME 1Q42.2-43

      American journal of human genetics
    53. Lidereau, R
      Breast cancer in situ: Somatic genetics

      EUROCANCER 98
    54. BIECHE I; KHODJA A; DRIOUCH K; LIDEREAU R
      GENETIC ALTERATION MAPPING ON CHROMOSOME-7 IN PRIMARY BREAST-CANCER

      Clinical cancer research
    55. BIECHE I; RUFFET E; ZWEIBAUM A; VILDE F; LIDEREAU R; FRANC B
      MUC1 MUCIN GENE, TRANSCRIPTS, AND PROTEIN IN ADENOMAS AND PAPILLARY CARCINOMAS OF THE THYROID

      Thyroid
    56. DRIOUCH K; DORIONBONNET F; BRIFFOD M; CHAMPEME MH; LONGY M; LIDEREAU R
      LOSS OF HETEROZYGOSITY ON CHROMOSOME ARM 16Q IN BREAST-CANCER METASTASES

      Genes, chromosomes & cancer
    57. DEVILEE P; HERMANS J; EYFJORD J; BORRESEN AL; LIDEREAU R; SOBOL H; BORG A; CLETONJANSEN AM; OLAH E; COHEN B; SCHERNECK S; HAMANN U; PETERLIN B; CALIGO M; BIGNON YL; MAUGARD C; ANDERSEN TI; ODEGAND AEM; BIECHE I; BIRNBAUM D; CORNELISSE CJ; SZTAN M; STEEL MR; SEITZ S; LOGAR N; GOLOUH R; GHIMENTI C; BRUELLE S; JOALLAND MP
      LOSS OF HETEROZYGOSITY AT 7Q31 IN BREAST-CANCER - RESULTS FROM AN INTERNATIONAL COLLABORATIVE STUDY-GROUP

      Genes, chromosomes & cancer
    58. BIECHE I; LIDEREAU R
      A GENE DOSAGE EFFECT IS RESPONSIBLE FOR HIGH OVEREXPRESSION OF THE MUC1 GENE OBSERVED IN HUMAN BREAST-TUMORS

      Cancer genetics and cytogenetics
    59. FERRANDO AA; PENDAS AM; LLANO E; VELASCO G; LIDEREAU R; LOPEZOTIN C
      GENE CHARACTERIZATION, PROMOTER ANALYSIS, AND CHROMOSOMAL LOCALIZATION OF HUMAN BLEOMYCIN HYDROLASE

      The Journal of biological chemistry
    60. LATIL A; CUSSENOT O; FOURNIER G; LIDEREAU R
      INFREQUENT ALLELIC IMBALANCE AT THE MAJOR SUSCEPTIBILITY HPC1 LOCUS IN SPORADIC PROSTATE TUMORS

      International journal of cancer
    61. LATIL A; CUSSENOT O; FOURNIER G; DRIOUCH K; LIDEREAU R
      LOSS OF HETEROZYGOSITY AT CHROMOSOME-16Q IN PROSTATE ADENOCARCINOMA -IDENTIFICATION OF 3 INDEPENDENT REGIONS

      Cancer research
    62. BELLET D; LAZAR V; BIECHE I; PARADIS V; GIOVANGRANDI Y; PATERLINI P; LIDEREAU R; BEDOSSA P; BIDART JM; VIDAUD M
      MALIGNANT TRANSFORMATION OF NONTROPHOBLASTIC CELLS IS ASSOCIATED WITHTHE EXPRESSION OF CHORIONIC-GONADOTROPIN BETA-GENES NORMALLY TRANSCRIBED IN TROPHOBLASTIC CELLS

      Cancer research
    63. BIECHE I; LIDEREAU R
      SOMATIC GENETIC ALTERATIONS IN BREAST-CAN CER

      Bulletin du cancer
    64. DRIOUCH K; CHAMPEME M; BEUZELIN M; BIECHE I; LIDEREAU R
      CLASSICAL GENE AMPLIFICATIONS IN HUMAN BREAST-CANCER ARE NOT ASSOCIATED WITH DISTANT SOLID METASTASES

      British Journal of Cancer
    65. BIECHE I; NOGUES C; RIVOILAN S; KHODJA A; LATIL A; LIDEREAU R
      PROGNOSTIC VALUE OF LOSS OF HETEROZYGOSITY AT BRCA2 IN HUMAN BREAST-CARCINOMA

      British Journal of Cancer
    66. SEROVASINILNIKOVA OM; BOUTRAND L; STOPPALYONNET D; BRESSACDEPAILLERETS B; DUBOIS V; LASSET C; JANIN N; BIGNON YJ; LONGY M; MAUGARD C; LIDEREAU R; LEROUX D; FREBOURG T; MAZOYER S; LENOIR GM
      BRCA2 MUTATIONS IN HEREDITARY BREAST AND OVARIAN-CANCER IN FRANCE

      American journal of human genetics
    67. BIECHE I; DEMURCIA G; LIDEREAU R
      POLY(ADP-RIBOSE) POLYMERASE GENE-EXPRESSION STATUS AND GENOMIC INSTABILITY IN HUMAN BREAST-CANCER

      Clinical cancer research
    68. SCHOLL S; BIECHE I; PALLUD C; CHAMPEME MH; BEUVON F; HACENE K; GULLICK W; POUILLART P; LIDEREAU R
      RELEVANCE OF MULTIPLE BIOLOGICAL PARAMETERS IN BREAST-CANCER PROGNOSIS

      Breast
    69. BIECHE I; CHAMPEME MH; LIDEREAU R
      LOSS AND GAIN OF DISTINCT REGIONS OF CHROMOSOME 1Q IN PRIMARY BREAST-CANCER

      Cytogenetics and cell genetics
    70. BIECHE I; LIDEREAU R
      A GENE DOSAGE EFFECT IS RESPONSIBLE FOR OVEREXPRESSION OF THE MUC1 GENE IN HUMAN BREAST-CANCER

      Cytogenetics and cell genetics
    71. SCHOLL SM; LIDEREAU R; DELAROCHEFORDIERE A; LENIR CCS; MOSSERI V; NOGUES C; POUILLART P; STANLEY ER
      CIRCULATING LEVELS OF THE MACROPHAGE-COLONY-STIMULATING FACTOR CSF-1 IN PRIMARY AND METASTATIC BREAST-CANCER PATIENTS - A PILOT-STUDY

      Breast cancer research and treatment
    72. JULIE C; BIECHE Y; RUFFET E; LIDEREAU R; FRANC B
      MUC-1 MUCIN EXPRESSION IN BENIGN ADENOMAS AND PAPILLARY CARCINOMAS OFTHE THYROID

      Laboratory investigation
    73. LATIL A; FOURNIER G; CUSSENOT O; LIDEREAU R
      DIFFERENTIAL CHROMOSOME ALLELIC IMBALANCE IN THE PROGRESSION OF HUMANPROSTATE-CANCER

      The Journal of urology
    74. LATIL A; CUSSENOT O; FOURNIER G; LIDEREAU R
      THE BRCA2 GENE IS NOT RELEVANT TO SPORADIC PROSTATE TUMORS

      International journal of cancer
    75. BIECHE I; TOMASETTO C; REGNIER CH; MOOGLUTZ C; RIO MC; LIDEREAU R
      2 DISTINCT AMPLIFIED REGIONS AT 17Q11-Q21 INVOLVED IN HUMAN PRIMARY BREAST-CANCER

      Cancer research
    76. LIDEREAU R
      GENETIC-MARKERS FOR PROGNOSIS AND THERAPE UTIC EFFECTS

      Bulletin du cancer
    77. SHENG ZM; MARCHETTI A; BUTTITTA F; CHAMPEME MH; CAMPANI D; BISTOCCHI M; LIDEREAU R; CALLAHAN R
      MULTIPLE REGIONS OF CHROMOSOME 6Q AFFECTED BY LOSS OF HETEROZYGOSITY IN PRIMARY HUMAN BREAST CARCINOMAS

      British Journal of Cancer
    78. LATIL A; CUSSENOT O; FOURNIER G; BARON JC; LIDEREAU R
      LOSS OF HETEROZYGOSITY AT 7Q31 IS A FREQUENT AND EARLY EVENT IN PROSTATE-CANCER

      Clinical cancer research
    79. BIECHE I; CHAMPEME MH; LIDEREAU R
      LOSS AND GAIN OF DISTINCT REGIONS OF CHROMOSOME 1Q IN PRIMARY BREAST-CANCER

      Clinical cancer research
    80. BIECHE I; LIDEREAU R
      GENETIC ALTERATIONS IN BREAST-CANCER

      Genes, chromosomes & cancer
    81. CHAMPEME MH; BIECHE I; BEUZELIN M; LIDEREAU R
      LOSS OF HETEROZYGOSITY ON 7Q31 OCCURS EARLY DURING BREAST TUMORIGENESIS

      Genes, chromosomes & cancer
    82. CHAMPEME MH; BIECHE I; LIZARD S; LIDEREAU R
      11Q13 AMPLIFICATION IN LOCAL RECURRENCE OF HUMAN PRIMARY BREAST-CANCER

      Genes, chromosomes & cancer
    83. CHAMPEME MH; MAZOYER S; STOPPALYONNET D; BIECHE I; ITHIER G; SOBOL H; NOGUES C; LIDEREAU R
      SUBLOCALIZATION OF SMALLEST COMMON REGIONS OF DELETION ON CHROMOSOME 17Q12-Q23 IN SPORADIC PRIMARY BREAST-TUMORS

      Oncology Reports
    84. DRIOUCH K; CHAMPEME MH; BEUZELIN M; BIECHE I; LIDEREAU R
      CLASSICAL GENE AMPLIFICATIONS IN HUMAN BREAST-CANCER ARE NOT RESPONSIBLE OF DISTANT METASTASES

      European journal of cancer
    85. COPIGNY F; CHAMPEME MH; BIECHE I; HACENE K; LIDEREAU R
      INT-2 FGF3 AMPLIFICATION IS BETTER INDEPENDENT PREDICTOR OF RELAPSE THAN C-MYC AND C-ERBB-2/NEU AMPLIFICATIONS IN PRIMARY HUMAN BREAST-CANCER/

      European journal of cancer
    86. BIECHE I; CHAMPEME MH; LIDEREAU R
      A TUMOR-SUPPRESSOR GENE ON CHROMOSOME 1P32-PTER CONTROLS THE AMPLIFICATION OF MYC FAMILY GENES IN BREAST-CANCER

      European journal of cancer
    87. CHAMPEME MH; BIECHE I; BEUZELIN M; LIDEREAU R
      LOSS OF HETEROZYGOSITY ON 7Q31 OCCURS EARLY DURING BREAST TUMORIGENESIS

      European journal of cancer
    88. LATIL A; CUSSENOT O; FOURNIER G; BARON JC; LIDEREAU R
      LOSS OF HETEROZYGOSITY AT 7Q31 IS A FREQUENT AND EARLY EVENT IN PROSTATE-CANCER

      European journal of cancer
    89. LIDEREAU R
      GENETIC ALTERATIONS IN BREAST-CANCER

      European journal of cancer
    90. KERANGUEVEN F; ESSIOUX L; DIB A; NOGUCHI T; ALLIONE F; GENEIX J; LONGY M; LIDEREAU R; EISINGER F; PEBUSQUE MJ; JACQUEMIER J; BONAITIPELLIE C; SOBOL H; BIRNBAUM D
      LOSS OF HETEROZYGOSITY AND LINKAGE ANALYSIS IN BREAST-CARCINOMA - INDICATION FOR A PUTATIVE 3RD SUSCEPTIBILITY GENE ON THE SHORT ARM OF CHROMOSOME-8

      Oncogene
    91. TOMASETTO C; REGNIER C; MOOGLUTZ C; MATTEI MG; CHENARD MP; LIDEREAU R; BASSET P; RIO MC
      IDENTIFICATION OF 4 NOVEL HUMAN GENES AMPLIFIED AND OVEREXPRESSED IN BREAST-CARCINOMA AND LOCALIZED TO THE Q11-Q21.3 REGION OF CHROMOSOME-17

      Genomics
    92. FOURNIER G; LATIL A; AMET Y; ABALAIN JH; VOLANT A; MANGIN P; FLOCH HH; LIDEREAU R
      GENE AMPLIFICATIONS IN ADVANCED-STAGE HUMAN PROSTATE-CANCER

      Urological research
    93. LIZARDNACOL S; LIDEREAU R; COLLIN F; ARNAL M; HAHNEL L; ROIGNOT P; CUISENIER J; GUERRIN J
      BENIGN BREAST DISEASE - ABSENCE OF GENETIC ALTERATIONS AT SEVERAL LOCI IMPLICATED IN BREAST-CANCER MALIGNANCY

      Cancer research
    94. LATIL A; BARON JC; CUSSENOT O; FOURNIER G; SOUSSI T; BOCCONGIBOD L; LEDUC A; ROUESSE J; LIDEREAU R
      GENETIC ALTERATIONS IN LOCALIZED PROSTATE -CANCER - IDENTIFICATION OFA COMMON REGION OF DELETION ON CHROMOSOME ARM 18Q

      Bulletin du cancer
    95. LATIL A; BARON JC; CUSSENOT O; FOURNIER G; SOUSSI T; BOCCONGIBOD L; LEDUC A; ROUESSE J; LIDEREAU R
      GENETIC ALTERATIONS IN LOCALIZED PROSTATE-CANCER - IDENTIFICATION OF A COMMON REGION OF DELETION ON CHROMOSOME ARM 18Q

      Genes, chromosomes & cancer
    96. KERANGUEVEN F; ADELAIDE J; DIB A; LONGY M; LIDEREAU R; PEBUSQUE MJ; JACQUEMIER J; BIRNBAUM D
      ALLELIC LOSS AT CHROMOSOME 8P IN HUMAN BREAST-CANCER

      Oncology Reports
    97. MULLER D; MILLON R; LIDEREAU R; ENGELMANN A; BRONNER G; FLESCH H; EBER M; METHLIN G; ABECASSIS J
      FREQUENT AMPLIFICATION OF 11Q13 DNA MARKERS IS ASSOCIATED WITH LYMPH-NODE INVOLVEMENT IN HUMAN HEAD AND NECK SQUAMOUS-CELL CARCINOMAS

      European journal of cancer. Part B, Oral oncology
    98. CHAMPEME MH; BIECHE I; HACENE K; LIDEREAU R
      ONCOGENE AMPLIFICATION PER SE - AN INDEPENDENT PROGNOSTIC FACTOR IN HUMAN BREAST-CANCER

      Molecular carcinogenesis
    99. CHAMPEME MH; BIECHE I; HACENE K; LIDEREAU R
      INT-2 FGF3 AMPLIFICATION IS A BETTER INDEPENDENT PREDICTOR OF RELAPSETHAN C-MYC AND C-ERBB-2/NEU AMPLIFICATIONS IN PRIMARY HUMAN BREAST-CANCER/

      Modern pathology
    100. LIDEREAU R; LATIL A; BARON JC; CUSSENOT O; FOURNIER G; SOUSSI T; BOCCONGIBOD L; LEDUC A; ROUESSE J
      GENETIC ALTERATIONS IN LOCALIZED PROSTATE-CANCER - IDENTIFICATION A COMMON REGION OF DELETION ON CHROMOSOME 18Q

      Journal of cellular biochemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 06:24:38